Immune disturbances in female genital tuberculosis and latent genital tuberculosis
- PMID: 36494901
- DOI: 10.1111/aji.13632
Immune disturbances in female genital tuberculosis and latent genital tuberculosis
Abstract
Background: Female genital tuberculosis (FGTB), an important clinical sub-type of extra-pulmonary tuberculosis (EPTB) is responsible for about 10% cases of infertility in India. Both FGTB and latent genital tuberculosis (LGTB) can cause infertility through blockage of fallopian tubes and through altered uterine endometrial receptivity.
Aims: This review tries to elucidates the role of various immune factors in FGTB and LGTB.
Content: Various immune disturbances are observed in FGTB and LGTB like growth factors and cytokines which inhibit implantation and several inflammatory signaling pathways like mitogen activated protein kinase (MAPK), natural killer (NK) cells, nuclear factor kappa-B (NF-KB), tumor necrosis factor (TNF), and toll like receptors (TLR) signaling are dysregulated. These altered immune factors and pathways may be detected in the endometrial biopsies at the early stages of disease before permanent damage. Prompt and adequate treatment with the four anti-tubercular drugs (rifampicin [R], isoniazid [H], pyrazinamide [Z], and ethambutol [E]) can increase pregnancy rates in some of these women. Assisted reproduction especially in-vitro fertilization and embryo transfer may be required for some women.
Implications: Inflammatory pathways identified from the gene profiling have enabled development of potential biomarkers for early diagnosis of FGTB. Immunomodulation and novel biotechniques like stem cell transplantation, nanoparticles and host directed therapies are being tried in selected patients of FGTB and LGTB with promising results.
Keywords: female genital tuberculosis (FGTB); immune factors; implantation; infertility; latent genital tuberculosis (LGTB).
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
References
REFERENCES
-
- World Health Organization. WHO global tuberculosis report 2020: WHO; 2021.
-
- Bruchfeld J, Correia-Neves M, Källenius G. Tuberculosis and HIV coinfection. Cold Spring Harb Perspect Med. 2015;5(7):a017871.
-
- Saunders MJ, Evans CA. COVID-19, tuberculosis and poverty: preventing a perfect storm. Eur Respir J. 2020;56(1):2001348.
-
- Hogan AB, Jewell BL, Sherrard-Smith E, et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020;8(9):e1132-e1141.
-
- Sharma JB, Sharma E, Sharma S, Dharmendra S. Recent advances in diagnosis and management of female genital tuberculosis. J Obstet Gynaecol India. 2021;71(5):1-12.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
